DK1061929T3 - Farmaceutisk præparat på basis af syntetisk naturligt progesteron og östradiol samt fremgangsmåde til fremstilling deraf - Google Patents

Farmaceutisk præparat på basis af syntetisk naturligt progesteron og östradiol samt fremgangsmåde til fremstilling deraf

Info

Publication number
DK1061929T3
DK1061929T3 DK99939161T DK99939161T DK1061929T3 DK 1061929 T3 DK1061929 T3 DK 1061929T3 DK 99939161 T DK99939161 T DK 99939161T DK 99939161 T DK99939161 T DK 99939161T DK 1061929 T3 DK1061929 T3 DK 1061929T3
Authority
DK
Denmark
Prior art keywords
oestradiol
pharmaceutical composition
preparation
synthetic natural
composition based
Prior art date
Application number
DK99939161T
Other languages
English (en)
Inventor
Benoit Agnus
Antoine Besins
Original Assignee
Besins Iscovesco Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Iscovesco Lab filed Critical Besins Iscovesco Lab
Application granted granted Critical
Publication of DK1061929T3 publication Critical patent/DK1061929T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK99939161T 1998-03-09 1999-03-08 Farmaceutisk præparat på basis af syntetisk naturligt progesteron og östradiol samt fremgangsmåde til fremstilling deraf DK1061929T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9802830A FR2775599B1 (fr) 1998-03-09 1998-03-09 Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation
PCT/FR1999/000515 WO1999045932A1 (fr) 1998-03-09 1999-03-08 Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation

Publications (1)

Publication Number Publication Date
DK1061929T3 true DK1061929T3 (da) 2005-08-29

Family

ID=9523802

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99939161T DK1061929T3 (da) 1998-03-09 1999-03-08 Farmaceutisk præparat på basis af syntetisk naturligt progesteron og östradiol samt fremgangsmåde til fremstilling deraf

Country Status (13)

Country Link
US (1) US6656929B1 (da)
EP (1) EP1061929B1 (da)
KR (1) KR20010034573A (da)
AT (1) ATE293979T1 (da)
AU (1) AU3259099A (da)
BR (1) BR9908622A (da)
CA (1) CA2323696C (da)
DE (1) DE69924987T2 (da)
DK (1) DK1061929T3 (da)
ES (1) ES2246578T3 (da)
FR (1) FR2775599B1 (da)
PT (1) PT1061929E (da)
WO (1) WO1999045932A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544553B1 (en) 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FR2821555B1 (fr) 2001-03-01 2003-05-16 Besins Int Lab Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations
US20110312927A1 (en) * 2010-06-18 2011-12-22 Satish Kumar Nachaegari Progesterone Containing Oral Dosage Forms and Related Methods
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
BR112016029338A2 (pt) 2014-07-29 2017-08-22 Therapeuticsmd Inc creme transdérmico
BR112017027688A2 (pt) 2015-06-22 2018-09-04 Lipocine Inc Composições orais que contêm éster de 17- hidroxiprogesterona e métodos relacionados
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2399243A2 (fr) * 1974-04-23 1979-03-02 Aries Robert Perfectionnements aux procedes, dispositifs et produits pour l'implantation d'hormones destinees a favoriser la croissance des animaux d'embouche
US4755386A (en) * 1986-01-22 1988-07-05 Schering Corporation Buccal formulation
US5073374A (en) * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
DK95093D0 (da) * 1993-08-20 1993-08-20 Novo Nordisk As Farmaceutisk formulering indeholdende et hormon
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19718012C1 (de) * 1997-04-29 1998-10-08 Jenapharm Gmbh Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe

Also Published As

Publication number Publication date
FR2775599B1 (fr) 2001-08-17
EP1061929A1 (fr) 2000-12-27
US6656929B1 (en) 2003-12-02
CA2323696A1 (fr) 1999-09-16
ES2246578T3 (es) 2006-02-16
WO1999045932A1 (fr) 1999-09-16
FR2775599A1 (fr) 1999-09-10
DE69924987D1 (de) 2005-06-02
DE69924987T2 (de) 2006-06-08
CA2323696C (fr) 2010-04-27
PT1061929E (pt) 2005-09-30
EP1061929B1 (fr) 2005-04-27
ATE293979T1 (de) 2005-05-15
BR9908622A (pt) 2000-11-14
KR20010034573A (ko) 2001-04-25
AU3259099A (en) 1999-09-27

Similar Documents

Publication Publication Date Title
DK1061929T3 (da) Farmaceutisk præparat på basis af syntetisk naturligt progesteron og östradiol samt fremgangsmåde til fremstilling deraf
EP0653795A3 (en) Double-implanted MOS device with lateral diffusion and manufacturing method.
DE59410116D1 (de) Kombinationsprodukt zur kontrazeption enthaltend progesteronantagonisten und gestagenen
DE69719360D1 (de) Zusammensetzungen und methoden zur steigerung der darmfunktion
NO303527B1 (no) Ïstrogenholdig medikament og anordning for transdermal administrering derav
PT1036058E (pt) Deribvados de adamantano
YU15299A (sh) Farmaceutski sastavi
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
AP9901674A0 (en) Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders.
TR199801679T2 (xx) Osteoporoz i�in birle�tirme terapisi.
RS49723B (sr) Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze
AP1703A (en) Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same.
TR199801511T2 (xx) Farmas�tik bile�im.
IL141914A0 (en) Dosage form comprising liquid formulation
FI963515A (fi) Laastarin muodossa oleva transdermaalinen systeemi, joka sisältää tamoksifeenijohdosta
MXPA04001388A (es) Dispositivo de retencion gastrica expandible.
TW200501943A (en) Escitalopram hydrobromide and a method for the preparation thereof
ATE245028T1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
ES2170396T3 (es) Composiciones farmaceuticas a base de diclofenac.
AR021249A1 (es) COMPOSICIoN DE CONFITURA BLANDA NO PEGAJOSA.
TR200000903T2 (tr) Romatizmal arteritlerin tedavisine yönelik yöntem ve kompozisyonlar.
ES2179375T3 (es) Composiciones farmaceuticas estabilizadas, a base de quinupristina y de dalfopristina y su preparacion.
NZ335602A (en) Soil conditioner containing at least one of Lacobacillus paracasei, Enterococcus malodoratus and Candida lipolytica and soil ameliorating method using the aforesaid
BG104914A (en) Paroxetine maleate
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions